product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
UCHL3 Antibody
catalog :
3525
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot, immunocytochemistry
citations: 2
Published Application/Species/Sample/DilutionReference
  • immunocytochemistry; mouse
Mtango N, Sutovsky M, Susor A, Zhong Z, Latham K, Sutovsky P. Essential role of maternal UCHL1 and UCHL3 in fertilization and preimplantation embryo development. J Cell Physiol. 2012;227:1592-603 pubmed publisher
Van Beekum O, Gao Y, Berger R, Koppen A, Kalkhoven E. A novel RNAi lethality rescue screen to identify regulators of adipogenesis. PLoS ONE. 2012;7:e37680 pubmed publisher
product information
SKU :
3525S
Product-Name :
UCHL3 Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Western blot
Product-Category :
Ubiquitin and Ubiquitin-like proteins
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
27
Host :
Rabbit
Target :
UCHL3
Primary-Protein :
UCHL3
Alt-Names :
UCH-L3,UCHL3,Ubiquitin carboxyl-terminal hydrolase isozyme L3,Ubiquitin thioesterase L3,ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase),ubiquitin thiolesterase
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.